In October 2022, the Company group's research and development (R&D) organization transitioned to the Deep Human Biology Learning (DHBL) drug discovery and development. Under the DHBL drug discovery ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback